Using a photo-reactive analog of 3.3 that forms a covalent adduct with LAMP1, we show that 3.3 is a competitive inhibitor of cholesterol binding to D1, the LAMP1 domain that binds to LASV GP during infection. This evidence concerns the gene LAMP1 and infection.